$STIM
Neuronetics Inc
PRICE
$3.335 ▲4.874%
Last Close
VOLUME
92,342
DAY RANGE
3.13 - 3.3438
52 WEEK
1.98 - 15
Key Metrics
Market Cap
84.68 M
Beta
1.30
Avg. Volume
316.13 K
Shares Outstanding
26.63 M
Yield
0%
Public Float
0
Next Earnings Date
2022-08-02
Next Dividend Date
Company Information
Neuronetics, Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its commercial product, the NeuroStar® Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The system is cleared by the United States Food and Drug Administration, or FDA, for the treatment of major depressive disorder in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. Visit NeuroStar.com for safety information and indications for use. NeuroStar is also available in other parts of the world, including Japan, where it is listed under Japan's national health insurance.
Website: www.neuronetics.com
HQ: 3222 Phoenixville Pike Malvern, 19355-9615 Pennsylvania
Related News
